Literature DB >> 7928233

New clinical trial experience with iopromide.

H A Goldstein1, G Jacob, J R Wiggins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7928233     DOI： 10.1097/00004424-199406001-00069

Source DB:  PubMed          Journal:  Invest Radiol        ISSN： 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  2 in total

1.  Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients.

Authors:  Jan Endrikat; Alexander Michel; Ralf Kölbach; Philipp Lengsfeld; Kai Vogtländer
Journal:  Invest Radiol       Date:  2020-01       Impact factor: 10.065

2.  Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations.

Authors:  Jan Endrikat; Julia Chernova; Christoph Gerlinger; Marcin Pracz; Philipp Lengsfeld; Aasia Bhatti; Alexander Michel
Journal:  Invest Radiol       Date:  2022-05-01       Impact factor: 6.016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.